United States · FDA National Drug Code directory

Lapatinib

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 0480-3237_f259a366-78fc-4919-9bcb-748314a0581c
Product NDC: 0480-3237
Form: TABLET, FILM COATED
Composition / generic term: Lapatinib
Labeler: Teva Pharmaceuticals, Inc.
Marketing category: ANDA
Marketing start / end (source format): 20241219
Source listing expiry: 20261231

Source-listed ingredients

LAPATINIB DITOSYLATE — 250 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

150 TABLET, FILM COATED in 1 BOTTLE (0480-3237-51) · 0480-3237-51

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →